Less-tight versus tight control of hypertension in pregnancy

New England Journal of Medicine

Volumn 372, Issue 5, 2015, Pages 407-417

  Magee, Laura A ^a   Von Dadelszen, Peter ^a   Rey, Evelyne ^b   Ross, Susan ^c   Asztalos, Elizabeth ^a,d   Murphy, Kellie E ^d   Menzies, Jennifer ^a   Sanchez, Johanna ^d   Singer, Joel ^a   Gafni, Amiram ^e   Gruslin, Andrée ^f   Helewa, Michael ^g   Hutton, Eileen ^e   Lee, Shoo K ^d   Lee, Terry ^a   Logan, Alexander G ^d   Ganzevoort, Wessel ⁱ   Welch, Ross ^j   Thornton, Jim G ^k   Moutquin, Jean Marie ^h  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h UNIVERSITÉ DE SHERBROOKE   (Canada)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

^j DERRIFORD HOSPITAL   (United Kingdom)

^k UNIVERSITY OF NOTTINGHAM   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; DISEASE SEVERITY; ECTOPIC PREGNANCY; FEMALE; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; LESS TIGHT CONTROL; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MULTICENTER STUDY; NEWBORN CARE; PERINATAL DEATH; PERINATAL PERIOD; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; TIGHT CONTROL; ABORTION, SPONTANEOUS; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; HYPERTENSION, PREGNANCY-INDUCED; NEWBORN; NEWBORN INTENSIVE CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; STATISTICS AND NUMERICAL DATA;

ABORTION, SPONTANEOUS; ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; PERINATAL DEATH; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PUERPERAL DISORDERS;

EID: 84921866509     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1404595     Document Type: Article

References (22)

1. Saftlas AF, Olson DR, Franks AL, Atrash AK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990; 163: 460-5.
2. Magee LA, Abalos E, von Dadelszen P, Sibai B, Walkinshaw SA. Control of hypertension in pregnancy. Curr Hypertens Rep 2009; 11: 429-36.
3. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376: 631-44.
4. Brown MA, Buddle ML. The importance of nonproteinuric hypertension in pregnancy. Hypertens Pregnancy 1995; 14: 57-65.
5. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2014; 2: CD002252.
6. El Guindy AA, Nabhan AF. A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy. J Perinat Med 2008; 36: 413-8.
7. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 2002; 24: 941-5.
8. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000; 355: 87-92.
9. Magee LA, von Dadelszen P, Chan S, et al. The Control of Hypertension In Pregnancy Study pilot trial. BJOG 2007; 114(6): 770-e13-20.
10. National Institute for Health and Care Excellence. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. NICE clinical guideline 107, August 2010 (https://www .nice .org .uk/guidance/cg107).
11. American College of Obstetricians and Gynecologists. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122-31.
12. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014; 36: 416-41.
13. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 2014; 4: 105-45.
14. Magee LA, Helewa M, Moutquin JM, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008; 30: Suppl: S1-S48.
15. Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105: 246-54.
16. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2003; 3: CD002863.
17. The 2013 Canadian Hypertension Education Program Recommendations (https://www .hypertension .ca/en/chep).
18. von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011; 377: 219-27.
19. Thompson SG, Warn DE, Turner RM. Bayesian methods for analysis of binary outcome data in cluster randomized trials on the absolute risk scale. Stat Med 2004; 23: 389-410.
20. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108(2): E35.
21. Lewis G, ed. The confidential enquiry into maternal and child health (CEMACH). Saving mothers' lives: reviewing maternal deaths to make motherhood safer - 2003-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH, 2007.
22. Arguedas JA, Perez MI, Wright JM. Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev 2009; 3: CD004349.